Norman David Eansor Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 18 hours ago
Norman David Eansor has an estimated net worth of at least $14.3 million*, as of yesterday. They own 8,468 shares of TECH stock. They have sold 27,159 shares of TECH stock since 2021, for an estimated $13.7 million.
Norman David Eansor $TECH SEC Form 4 Insider Trading
Norman David Eansor has filed a total of 10 insider trades in $TECH since 2021. Their most recent trade was a sale of 200 shares, made on Nov 12, 2021. Their largest trade was a sale of 9,043 shares, made on Nov 12, 2021. We estimate that they now own 8,468 shares of $TECH, worth an estimated $626,416.
Insider Trading at $TECH
There have been a total of 79 insider trades reported at $TECH since 2021, with 300 shares purchased and 242,388 shares sold. The most active insider traders in $TECH stock have been James Hippel, Charles R. Kummeth, and Norman David Eansor. The most recent trade was a sale of 16,000 shares reported by ROBERT V BAUMGARTNER (None), made on Aug 08, 2024.
History of Insider Stock Trades by Norman David Eansor
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
MRKR | Purchase | 14,285 | Mar 16, 2021 | June 8, 2023, 9:35 p.m. |
TECH | Sale | 200 | Nov 12, 2021 | Nov. 15, 2021, 8 p.m. |
TECH | Sale | 300 | Nov 12, 2021 | Nov. 15, 2021, 8 p.m. |
TECH | Sale | 537 | Nov 12, 2021 | Nov. 15, 2021, 8 p.m. |
TECH | Sale | 400 | Nov 12, 2021 | Nov. 15, 2021, 8 p.m. |
TECH | Sale | 700 | Nov 12, 2021 | Nov. 15, 2021, 8 p.m. |
TECH | Sale | 9,043 | Nov 12, 2021 | Nov. 15, 2021, 8 p.m. |
TECH | Sale | 8,989 | Nov 12, 2021 | Nov. 15, 2021, 8 p.m. |
TECH | Sale | 2,535 | Nov 12, 2021 | Nov. 15, 2021, 8 p.m. |
TECH | Sale | 401 | Nov 12, 2021 | Nov. 15, 2021, 8 p.m. |
TECH | Sale | 4,054 | Nov 12, 2021 | Nov. 15, 2021, 8 p.m. |
$TECH Executives and Stock Owners with Insider Trades
-
James Hippel, Chief Financial Officer
-
Charles R. Kummeth, Chief Executive Officer
-
Norman David Eansor, President-Protein Sciences
-
Kim Kelderman, Pres. Diagnostics & Genom
-
Brenda S. Furlow, SVP - General Counsel
-
Brenda S. Furlow, SVP - GENERAL COUNSEL
-
Charles R. Kummeth, CHIEF EXECUTIVE OFFICER
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.